Medical/Pharmaceuticals
Zuellig Pharma Singapore Named 'Industry Champions of the Year' at the Asia Corporate Excellence & Sustainability Awards 2021
SINGAPORE, Aug. 11, 2021 /PRNewswire/ -- Zuellig Pharma Singapore, a leading healthcare services provider inSingapore, has been presented with the 'Industry Champions of the Year' title at the recent Asia Corporate Excellence and Sustainability (ACES) Awards. Held annually, the ACES Awards is a p...
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP in China
BEIJING, Aug. 10, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today the Investigational New Drug (IND) approval of its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib by China National Medical Products Administration (NMPA) for startin...
Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021 Exploring The Profiles Of Australian Contour®Diabetes App Users
SYDNEY, Aug. 11, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes placeAugust 11-13. The two posters presented for the first time data that analysed CONTOUR®DIABETES App (CDA) us...
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China
SHANGHAI, Aug. 10, 2021 /PRNewswire/ -- On August 10th, 2021,Belief Biomed announced thatChina's National Medical Products Administration (NMPA) has cleared the IND (Investigational New Drug) application for Belief Biomed's BBM-H901. This marks the first IND approval for Intravenous (i.v.) infusi...
DERMALOG is one of Germany's most innovative SMEs
Again, DERMALOG has been ranked as one of the most innovative companies in Germany this year. The biometrics company thus ranks in the top group as number 14 of the approximately 4,000 German companies evaluated HAMBURG, Germany, Aug. 10, 2021 /PRNewswire/ -- The German WirtschaftsWoche magazine...
Novaliq Completes Enrollment of Second Phase 3 Study for CyclASol® for the Treatment of Dry Eye Disease
HEIDELBERG, Germany and CAMBRIDGE, MA, Aug. 10, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the second of two Phase 3 (ESSENCE-2) studies, evaluating the inves...
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with Its Systems Integration Solution
LONDON, Aug 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global market for operating room (OR) systems integration,Frost & Sullivan recognizes FUJIFILM Medical SystemsUSA, Inc. with the 2021 Global New Product Innovation Award. Its systems integration solution comprising Intellige...
Dymicron® Names Gunther Peeters as Senior Vice President of Commercial Operations
Gunther Peeters to spearhead international commercialization of Dymicron's next-generation cervical disc replacement system OREM, Utah, Aug. 10, 2021 /PRNewswire/ -- Dymicron today announced it has appointedGunther Peeters as Senior Vice President of Commercial Operations. With more than 15 year...
Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine
* Contributing to society and patients through the utilization of iPSC technology developed inJapan * New company to advance two successful outcomes from T-CiRA collaboration for severe heart failure and type I diabetes to clinical application of iPSC-based medicine KYOTO, Japan, Aug. 10, 2...
Australia's Cancer Organisations Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster' During Pandemic
'New Normal, Same Cancer: Conversations' warns people to get unusual and persistent symptoms checked by their doctor now, to increase detection and improve survival chances, following a slump in cancer testing and screening during the COVID-19 pandemic. * Growing concern among Australian cance...
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation between Arvinas' and Insilico Medicine's scientists on novel PR...
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand
BEIJING, Aug. 9, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it received IND clearance for PIKA recombinant COVID-19 vaccine (CHO cell, S Protein) to conduct Phase I clinical trial from New Zealand Medicines and Medical Devices Safety Authority ("MEDSAFE"), which ...
111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow
SHANGHAI, Aug. 9, 2021 /PRNewswire/ – 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results f...
Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users
The US digital therapeutics market is estimated to witness more than three-and-a-half-fold growth reaching$4.54 billion by 2025, at a CAGR of 29.8%, finds Frost & Sullivan SANTA CLARA, Calif., Aug. 9, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) i...
Thailand's Jan-June Investment Applications Reach USD12 billion, as FDI Quadruple, E&E and Medical Sectors Continue to Expand, BOI says
BANGKOK, Aug. 9, 2021 /PRNewswire/ -- In the first six months of 2021, Thailand's investment applications increased 14% from the year earlier period in terms of the number of projects, and 158% in combined value, led by increasing foreign direct investment (FDI) applications, sustained growth in ...
Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets
SHANGHAI and HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
HANGZHOU and SHAOXING, China, Aug. 9, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase II clinical trial application of ASC40 for the treatment of patients with moderate to severe acne. T...
Innovent Announces the Establishment of the Scientific Advisory Board
SAN FRANCISCO and SUZHOU, China, Aug. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
Insightec Announces Seoul National University Hospital Is Installing Exablate Neuro Platform
Expanding patient access to incision-free Focused Ultrasound treatment
HAIFA, Israel and MIAMI, Aug. 9, 2021 /PRNewswire/ -- Insightec
NUH's Smallest Surviving Baby Discharged Well to Home
SINGAPORE, Aug. 7, 2021 /PRNewswire/ -- Kwek Yu Xuan is a 14-month-old infant who had undergone and survived an incredible life battle when she first came into the world. Born prematurely at 212 grams on9 June 2020, in the midst of the global COVID-19 pandemic, this small and fragile baby had a l...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 291 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 290 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00